<bill session="118" type="h" number="4702" updated="2025-11-19T04:59:18Z">
  <state datetime="2023-07-18">REFERRED</state>
  <status>
    <introduced datetime="2023-07-18"/>
  </status>
  <introduced datetime="2023-07-18"/>
  <titles>
    <title type="display">Securing Gene Synthesis Act</title>
    <title type="short" as="introduced">Securing Gene Synthesis Act</title>
    <title type="official" as="introduced">To require the Secretary of Health and Human Services to prescribe a regulation reducing the risks in gene synthesis products, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="E000215"/>
  <cosponsors>
    <cosponsor bioguide_id="B001285" joined="2024-02-15"/>
    <cosponsor bioguide_id="L000582" joined="2023-09-12"/>
  </cosponsors>
  <actions>
    <action datetime="2023-07-18">
      <text>Introduced in House</text>
    </action>
    <action datetime="2023-07-18" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2023-07-21">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referred To"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="118" type="s" number="2400" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Congressional oversight"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Genetics"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Medical research"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments/>
  <summary date="2024-10-03T20:52:31Z" status="Introduced in House">Securing Gene Synthesis Act

This bill requires the Department of Health and Human Services to issue regulations to prevent the misuse of de novo gene synthesis products (i.e., manufactured gene products), including screening protocols for providers of these products. Federal agencies and entities that receive federal funds may only purchase such products from providers that comply with the screening protocols.</summary>
</bill>
